Therapeutic, refractive uses await CXL

The six fellowship-trained cornea specialist partners and I at Minnesota Eye Consultants are deeply engaged in corneal cross-linking.
More than a decade ago, we participated in the Peschke clinical trial that provided the data leading to FDA approval for Avedro. We then participated in a similar trial sponsored by Topcon that was never submitted for approval. Both of these trials utilized the classical epithelium-off so-called Dresden protocol developed by Theo Seiler, MD, PhD, and his associates. We then joined the CXLUSA clinical trial and participated in the development and study (Read more...)

Full Story →